What You Should Know:
- NOCDand Talkiatry, today announced a partnership to offer treatment to people with OCD who need both medication management as well as access to exposure response therapy – the gold standard in treating this chronic condition.
- Through this strategic new partnership, NOCD therapists can refer patients to Talkiatry for thorough psychiatric evaluations and medication management, while Talkiatry’s psychiatrists can refer patients to NOCD for specialized ERP therapy—the gold standard of treatment when delivered together.
Strengthen OCD Care Journeys
When left untreated, OCD can lead to an increased risk of suicide. Untreated OCD also frequently co-occurs with other mental health conditions, such as anxiety disorders, depression, and substance use disorders, and the presence of these comorbidities increases the complexity of treatment and results in higher healthcare utilization and associated costs.
The partnership between Talkiatry and NOCD brings together two innovative practices that share a common goal of providing accessible and effective mental health care. This collaborative effort recognizes the unique challenges individuals face when seeking specialized care for OCD and aims to bridge the gap for patients by streamlining the referral process and centralizing comprehensive care.
“By working together, Talkiatry and NOCD can reduce the frequency and intensity of OCD symptoms, improve coping strategies, and enhance the overall functioning and well-being of our mutual patients,” said Robert Krayn, co-founder and CEO, Talkiatry. “This collaboration builds on Talkiatry’s partnership strategy with specialty providers and large health systems to streamline referral processes. Talkiatry and NOCD are dedicated to improving the lives of individuals struggling with mental health challenges by providing evidence-based care and breaking down barriers to accessing quality mental health care.”
